|
Molecular Design International |
|
|
111 South Highland Street
Memphis, TN 38111 USA
phone:901.529.1919
fax:901.522.8772
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.moleculardesign.com
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Discovers, patents, and evaluates new drug candidates. |
|
| Management |
| William P. Purcell, Ph. D., the founder and majority shareholder of MDI |
| |
|
|
| |
|
| Keywords |
| oncology, dermatology, female sexual dysfunction, obesity |
|
|
|
| Description |
|
Molecular Design International (MDI) discovers, patents, and evaluates new drug candidates. |
|
| Technology / Differentiation |
| Molecular Design International is focused in the fields of oncology, dermatology, female sexual dysfunction and obesity. In MDI's Drug Portfolio, Obesity is currently out licensed to a large pharmaceutical company. Available for Licensing is Sexual Dysfunction and Oncology, both in Preclinical tests. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members